Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT00643058
Eligibility Criteria:
Inclusion Criteria:
* Willing/able to give informed consent \& adhere to visit/protocol schedules
* non-atopic, non-asthmatic by PFT and allergy skin testing
* never cigarette smoker,
* no significant occupational exposure to respiratory irritants or toxins,
* no chronic illness
* no chronic use of medications (excluding contraceptive medication),
* no systemic corticosteroid use in the previous month,
* no historical or physical examination evidence of unstable cardiac or severe lung disease,
* Women of childbearing potential must have a negative serum pregnancy test
* baseline FEV1 \> 80% of the predicted value,
* no clinically significant abnormalities on the chest x-ray or EKG
Exclusion Criteria:
* occupational exposure to hay or grain
* smoked 20 or more packs of cigarettes in a lifetime.
* prior allergen immunotherapy
* Allergy to potential study medications acetaminophen and albuterol
* Subjects who abuse alcohol or illicit substances will be excluded
* Viral respiratory infection within the previous 14 days
* Students or employees under direct supervision by protocol investigators are ineligible
* Nursing mothers
* Other investigational medication within the last 30 days
* Other medical or psychological conditions which, in the opinion of the investigator, might create undue risk to the subject or interfere with the subject's ability to comply with the protocol requirements
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT00643058
Study Brief:
Protocol Section:
NCT00643058